Not the 4iu single doses. Pharma removes any concern about sterility / contaminants, a pharma formulation is explicitly designed to prevent aggregation, and since it’s reconstituted with sterile water for injection (not BAC) and used immediately, the risk of degradation / aggregation from time/temp exposure is absolutely minimal.
I would for multi-dose vials though, not for safety, like with UGL, but because results from removing the “acceptable” level of aggregation pharma / FDA allows (which is established during the approval process) over the period multi dose vials are permitted to sit in reconstituted form is still better off being removed. It’s completely optional though, and just my preference knowing what I’ve learned about the practice of “bedside filtration” of pharma proteins being advocated by some experts and used in some hospitals.